“We aspire to be the most respected and valued biotech in India, exemplified through a pipeline of compounds in clinical development addressing critical needs in Oncology and Auto-immune therapeutic areas”
In order to realize this Mission, Aurigene has pioneered a unique model: A revenue generating Drug Discovery collaboration and Services model, coupled with Early/ Clinical Stage Licensing of its proprietary assets.
Aurigene aims to:
- Add to the clinical development portfolio of our Partners in our collaboration model
- License its proprietary assets at pre-clinical/ clinical stage to generate value
- Retain development and commercial rights in specific geographies for its proprietary pipeline